Literature DB >> 8150893

Development and validation of a Multiple Ability Self-Report Questionnaire.

M Seidenberg1, A Haltiner, M A Taylor, B B Hermann, A Wyler.   

Abstract

We present results from three studies on the development and validation of the Multiple Ability Self-Report Questionnaire (MASQ), a self-report measure comprising items from five cognitive domains; language, visuo-perceptual, verbal memory, visual memory, and attention. In Study 1, we determined the content relevance of the questionnaire items. In Study 2, we assessed the basic psychometric properties (i.e., internal consistency and test-retest reliability) of the MASQ in 118 individuals without neurologic or psychiatric disorder, aged 25 to 88 years. In Study 3 we provide validity data for the MASQ by comparing the ratings of normals to people with unilateral temporal-lobe epilepsy, and examining the relationship of self-report to objective test performance. The potential use of the MASQ to study the neurologic and psychological correlates of accuracy and unawareness in self-appraisal across different cognitive domains and various clinical groups is discussed.

Entities:  

Mesh:

Year:  1994        PMID: 8150893     DOI: 10.1080/01688639408402620

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  64 in total

Review 1.  An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.

Authors:  Yin Ting Cheung; Earl Hsien-Jie Tan; Alexandre Chan
Journal:  Support Care Cancer       Date:  2012-04-05       Impact factor: 3.603

2.  Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia.

Authors:  Jennifer M Glass; David A Williams; Maria-Luisa Fernandez-Sanchez; Anson Kairys; Paloma Barjola; Mary M Heitzeg; Daniel J Clauw; Tobias Schmidt-Wilcke
Journal:  J Pain       Date:  2011-09-25       Impact factor: 5.820

3.  Attitudes toward information about genetic risk for cognitive impairment after cancer chemotherapy: breast cancer survivors compared with healthy controls.

Authors:  Michael A Andrykowski; Jessica L Burris; Erin Walsh; Brent J Small; Paul B Jacobsen
Journal:  J Clin Oncol       Date:  2010-05-24       Impact factor: 44.544

4.  Development of responder definitions for fibromyalgia clinical trials.

Authors:  Lesley M Arnold; David A Williams; James I Hudson; Susan A Martin; Daniel J Clauw; Leslie J Crofford; Fujun Wang; Birol Emir; Chinglin Lai; Rong Zablocki; Philip J Mease
Journal:  Arthritis Rheum       Date:  2012-03

5.  Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial.

Authors:  Robert J Ferguson; Brenna C McDonald; Michael A Rocque; Charlotte T Furstenberg; Susan Horrigan; Tim A Ahles; Andrew J Saykin
Journal:  Psychooncology       Date:  2010-12-02       Impact factor: 3.894

6.  Towards patient collaboration in cognitive assessment: Specificity, sensitivity, and incremental validity of self-report.

Authors:  C E Schwartz; E Kozora; Q Zeng
Journal:  Ann Behav Med       Date:  1996-09

Review 7.  Advances in the assessment of fibromyalgia.

Authors:  David A Williams; Stephen Schilling
Journal:  Rheum Dis Clin North Am       Date:  2009-05       Impact factor: 2.670

8.  A Comparison of Fibromyalgia Symptoms in Patients with Healthy versus Depressive, Low and Reactive Affect Balance Styles.

Authors:  Loren L Toussaint; Ann Vincent; Samantha J McAllister; Terry H Oh; Afton L Hassett
Journal:  Scand J Pain       Date:  2014-07-01

9.  Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.

Authors:  Robert J Ferguson; Brenna C McDonald; Andrew J Saykin; Tim A Ahles
Journal:  J Clin Oncol       Date:  2007-09-01       Impact factor: 44.544

10.  Effect of estrogen depletion on pain sensitivity in aromatase inhibitor-treated women with early-stage breast cancer.

Authors:  N Lynn Henry; Anna Conlon; Kelley M Kidwell; Kent Griffith; Jeffrey B Smerage; Anne F Schott; Daniel F Hayes; David A Williams; Daniel J Clauw; Steven E Harte
Journal:  J Pain       Date:  2014-01-22       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.